​

Regencell Bioscience Ownership | Who Owns Regencell Bioscience?

OverviewChart

Regencell Bioscience Ownership Summary

Regencell Bioscience is owned by 0.07% institutional investors, 93.84% insiders, and 6.10% retail investors. Blackrock is the largest institutional shareholder, holding 0.00% of RGC shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.05% of its assets in Regencell Bioscience shares.

RGC Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRegencell Bioscience0.07%93.84%6.10%
SectorHealthcare Stocks 279.18%10.62%-189.80%
IndustrySpecialty & Generic Drug Manufacturers Stocks2774.71%11.85%-2686.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock238.000.00%$800.00
Blackrock funding, inc. /de238.000.00%$1.18K
Ubs group---
Qube research---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blackrock238.00-$800.00
Ubs group---
Qube research---
Blackrock funding, inc. /de238.00-$1.18K

Top Buyers

HolderShares% AssetsChange
Blackrock238.00--
Blackrock funding, inc. /de238.00--
Qube research---13.00
Ubs group---29.22K

Top Sellers

HolderShares% AssetsChange
Ubs group---29.22K
Qube research---13.00
Blackrock238.00--
Blackrock funding, inc. /de238.00--

Sold Out

HolderChange
Qube research-13.00
Ubs group-29.22K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025566.67%8,830-72.02%-115.38%4100.00%1-
Dec 31, 2024350.00%31,55674.21%-1251.51%2---
Sep 30, 20242-33.33%18,1143117.41%-748234.88%2---100.00%
Jun 30, 20243-563-65.90%-2685.04%--1-
Mar 31, 20243-1,651-89.87%-80.85%--100.00%1-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Nasdaq Composite Index6.82K0.05%-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 29, 2017BELL THOMAS D JR-Buy$369.00K
Aug 25, 2017KAPLAN STEPHEN A-Buy$148.70K
Aug 24, 2017Ownby David EVP, CFO and TreasurerBuy$105.30K
Mar 09, 2017BRANDOW PETER B EVP, General Counsel, Sec.Sell$455.24K
Mar 09, 2017DUNN GREGORY W President and COOSell$577.01K

RGC Ownership FAQ

Who Owns Regencell Bioscience?

Regencell Bioscience shareholders are primarily institutional investors at 0.07%, followed by 93.84% insiders and 6.09% retail investors. The average institutional ownership in Regencell Bioscience's industry, Specialty & Generic Drug Manufacturers Stocks, is 2774.71%, which Regencell Bioscience falls below.

Who owns the most shares of Regencell Bioscience?

Regencell Bioscience’s largest shareholders are Blackrock (238 shares, 0.00%), Blackrock funding, inc. /de (238 shares, 0.00%), and Ubs group (0 shares, 0%). Together, they hold 0.00% of Regencell Bioscience’s total shares outstanding.

Does Blackrock own Regencell Bioscience?

Yes, BlackRock owns 0.00% of Regencell Bioscience, totaling 238 shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 800$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Regencell Bioscience’s biggest shareholder by percentage of total assets invested?

Blackrock is Regencell Bioscience’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 238 Regencell Bioscience shares, valued at 800$.

Who is the top mutual fund holder of Regencell Bioscience shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Regencell Bioscience shares, with 0.05% of its total shares outstanding invested in 6.82K Regencell Bioscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools